Home - Products - Others - Other Targets - 5-Amino-4-imidazolecarboxamide

5-Amino-4-imidazolecarboxamide

CAS No. 21299-72-9

5-Amino-4-imidazolecarboxamide ( —— )

Catalog No. M13390 CAS No. 21299-72-9

An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.

Purity : >98%(HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
10MG	45	In Stock
25MG	61	In Stock
50MG	98	In Stock
100MG	129	In Stock
200MG	181	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Group Booking Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

5-Amino-4-imidazolecarboxamide
Note

Research use only, not for human use.
Brief Description

An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC.
Description

An imidazole derivative which is a metabolite of the antineoplastic agents BIC and DIC. By itself, or as the ribonucleotide, it is used as a condensation agent in the preparation of nucleosides and nucleotides. Compounded with orotic acid, it is used to treat liver diseases.
Synonyms

——
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

21299-72-9
Formula Weight

126.12
Molecular Formula

C4H6N4O
Purity

>98%(HPLC)
Solubility

Limited solubility
SMILES

Cl.NC(=O)C1=C(N)N=CN1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.Velavan A, et al. Org Biomol Chem. 2012 Aug 21;10(31):6420-3

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

[Phe1Ψ(CH2-NH)Gly2]N...

Potent agonist of the nociceptin (ORL1) receptor, demonstrated both in vitro and in vivo. Selective, competitive antagonism at the nociceptin receptor has also been reported (pA2 = 7.02 and 6.75 in the guinea pig ileum and mouse vas deferens respectively).
Tectoruside

Tectoruside is a natural product from Iris tectorum.
VULM 1457

VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes.

Sign In Join Free